These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21436223)

  • 1. Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety.
    Pickering EE; Semple SJ; Nazir MS; Murphy K; Snow TM; Cummin AR; Moosavi SH; Guz A; Holdcroft A
    Chron Respir Dis; 2011; 8(2):109-18. PubMed ID: 21436223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD.
    Gifford AH; Mahler DA; Waterman LA; Ward J; Kraemer WJ; Kupchak BR; Baird JC
    COPD; 2011 Jun; 8(3):160-6. PubMed ID: 21513438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
    Johnson JR; Burnell-Nugent M; Lossignol D; Ganae-Motan ED; Potts R; Fallon MT
    J Pain Symptom Manage; 2010 Feb; 39(2):167-79. PubMed ID: 19896326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
    Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
    J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
    Abdallah SJ; Smith BM; Ware MA; Moore M; Li PZ; Bourbeau J; Jensen D
    Ann Am Thorac Soc; 2018 Oct; 15(10):1146-1158. PubMed ID: 30049223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.
    Abernethy AP; Currow DC; Frith P; Fazekas BS; McHugh A; Bui C
    BMJ; 2003 Sep; 327(7414):523-8. PubMed ID: 12958109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (COPD).
    Grazzini M; Stendardi L; Gigliotti F; Scano G
    Respir Med; 2005 Nov; 99(11):1403-12. PubMed ID: 16210095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Behavioral Therapy for Management of Dyspnea: A Pilot Study.
    Williams MT; Cafarella P; Paquet C; Frith P
    Respir Care; 2015 Sep; 60(9):1303-13. PubMed ID: 25969515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.
    Notcutt W; Price M; Miller R; Newport S; Phillips C; Simmons S; Sansom C
    Anaesthesia; 2004 May; 59(5):440-52. PubMed ID: 15096238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temazepam 10mg does not affect breathing and gas exchange in patients with severe normocapnic COPD.
    Stege G; Heijdra YF; van den Elshout FJ; van de Ven MJ; de Bruijn PJ; van Sorge AA; Dekhuijzen PN; Vos PJ
    Respir Med; 2010 Apr; 104(4):518-24. PubMed ID: 19910177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases.
    Woodcock AA; Gross ER; Gellert A; Shah S; Johnson M; Geddes DM
    N Engl J Med; 1981 Dec; 305(27):1611-6. PubMed ID: 6796885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure.
    Caroci Ade S; Lareau SC
    Heart Lung; 2004; 33(2):102-10. PubMed ID: 15024375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.
    Charles MA; Reymond L; Israel F
    J Pain Symptom Manage; 2008 Jul; 36(1):29-38. PubMed ID: 18358689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report.
    Farquhar M; Higginson IJ; Fagan P; Booth S
    Palliat Support Care; 2010 Jun; 8(2):143-9. PubMed ID: 20307365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers.
    Kaufmann RM; Kraft B; Frey R; Winkler D; Weiszenbichler S; Bäcker C; Kasper S; Kress HG
    Pharmacopsychiatry; 2010 Jan; 43(1):24-32. PubMed ID: 20178093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.